- Open Access
Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein
© Valas et al; licensee BioMed Central Ltd. 2008
- Received: 09 October 2007
- Accepted: 29 February 2008
- Published: 29 February 2008
Lentiviral genomes encode multiple structural and regulatory proteins. Expression of the full complement of viral proteins is accomplished in part by alternative splicing of the genomic RNA. Caprine arthritis encephalitis virus (CAEV) and maedi-visna virus (MVV) are two highly related small-ruminant lentiviruses (SRLVs) that infect goats and sheep. Their genome seems to be less complex than those of primate lentiviruses since SRLVs encode only three auxiliary proteins, namely, Tat, Rev, and Vif, in addition to the products of gag, pol, and env genes common to all retroviruses. Here, we investigated the central part of the SRLV genome to identify new splice elements and their relevance in viral mRNA and protein expression.
We demonstrated the existence of a new 5' splice (SD) site located within the central part of CAEV genome, 17 nucleotides downstream from the SD site used for the rev mRNA synthesis, and perfectly conserved among SRLV strains. This new SD site was found to be functional in both transfected and infected cells, leading to the production of a transcript containing an open reading frame generated by the splice junction with the 3' splice site used for the rev mRNA synthesis. This open reading frame encodes two major protein isoforms of 18- and 17-kDa, named Rtm, in which the N-terminal domain shared by the Env precursor and Rev proteins is fused to the entire cytoplasmic tail of the transmembrane glycoprotein. Immunoprecipitations using monospecific antibodies provided evidence for the expression of the Rtm isoforms in infected cells. The Rtm protein interacts specifically with the cytoplasmic domain of the transmembrane glycoprotein in vitro, and its expression impairs the fusion activity of the Env protein.
The characterization of a novel CAEV protein, named Rtm, which is produced by an additional multiply-spliced mRNA, indicated that the splicing pattern of CAEV genome is more complex than previously reported, generating greater protein diversity. The high conservation of the SD site used for the rtm mRNA synthesis among CAEV and MVV strains strongly suggests that the Rtm protein plays a role in SRLV propagation in vivo, likely by competing with Env protein functions.
- Cytoplasmic Domain
- Equine Infectious Anemia Virus
- Fusion Activity
- Splice Activity
- Caprine Arthritis Encephalitis Virus
Caprine arthritis encephalitis virus (CAEV) and ovine maedi-visna virus (MVV) are small-ruminant lentiviruses (SRLVs) that cause slow and persistent inflammatory diseases primarily in the joints, lungs, central nervous system, and mammary glands of sheep and goats . In vivo, the predominant target cells of SRLV infection are of the monocyte/macrophage lineage [2, 3]. Several lines of evidence suggest that SRLVs have evolved complex strategies to escape the host immune control. Virus exposure to the host immune response is limited because infected circulating monocytes do not express a threshold level of viral mRNA necessary to allow virus production , and only differentiated tissue macrophages are permissive to SRLV infection [4, 5]. A large fraction of infectious particles accumulates in intracellular vesicles of SRLV-infected cells [3, 4, 6–9], sequestering virus from host defense mechanisms. Together, the nonproductive infection of circulating monocytes and the assembly of viral structural products in specific intracellular compartments, presumably promote efficient dissemination and persistence of virus into the host. However, cellular and viral factors involved in the control of SRLV expression are still largely unknown.
The genomic organization of SRLVs appears to be less complex than those of primate lentiviruses. In addition to the gag, pol, and env genes coding for the structural proteins and enzymes common to all retroviruses, SRLVs encode three auxiliary proteins, namely, Tat, Rev, and Vif. The SRLV Tat protein was initially described as a trans-activator protein which weakly enhances the transcription initiation from the viral promoter [10, 11]. Recent studies demonstrating the incorporation of this protein into viral particles and its ability to mediate cell cycle arrest in the G2/M phase led to the conclusion that the SRLV Tat protein would better be considered as an accessory protein similar to the Vpr protein of the primate lentiviruses . The Rev protein allows the cytoplasmic expression of the incompletely spliced SRLV mRNAs that encode the structural proteins [13, 14]. Thus, Rev is required for virus gene expression and replication. The Vif protein acts at the late stage of virus formation and/or release , and is required for viral replication in vivo [16, 17].
The expression of the various SRLV gene products is complex and temporally regulated [18–20]. The production of the full panel of the different spliced messages is achieved by alternative splicing using many splice sites, most of them being located in the pol/env intermediate region of the SRLV genome. The fine tuning of each viral mRNA level regulates the ratio of the different SRLV proteins. Initially, the multiply-spliced transcripts that encode the Tat and Rev regulatory proteins are predominant. Then, a Rev-mediated transition occurs to permit the cytoplasmic accumulation of singly-spliced and full-length RNA species encoding the viral structural and enzymatic proteins. In CAEV-infected cells, Vif and Env are expressed from different singly-spliced mRNAs, Tat and Rev are each encoded by at least two alternatively multiply-spliced mRNAs [18, 21, 22].
Here, we report the identification of a novel 5' splice (SD) site highly conserved in all SRLV genomes sequenced to date. The sequence of this SD site matches perfectly the canonical SD site. In CAEV-infected cells, the use of this SD site leads to an alternatively spliced mRNA that encodes two major protein isoforms of 18- and 17-kDa, designated Rtm. These proteins are expressed in infected cells and contain the N-terminal part of Env/Rev fused to the entire cytoplasmic domain of the transmembrane glycoprotein (TM). The Rtm proteins interact specifically with the cytoplasmic domain of TM in vitro, and modulate the fusion activity of viral envelope glycoproteins.
The SD6140site is competent for splicing activity
Sequence analysis of the 660 nt PCR product confirmed the junction between the SD6140 and SA8514 sites (data not shown), demonstrating that the CAEV genome contains an additional SD site at position 6140, leading to a new splicing event within the Env coding region.
Analysis of RT-PCR fragments from cells transfected with plasmid pKR12 containing the native viral sequence revealed a spliced product shorter than that obtained with plasmid pKRm in which the SD6123 was disrupted (Fig. 2B, compare lines 2 and 3), suggesting that no or few splicing occured at the SD6140 site in the presence of the upstream SD6123 site. To determine whether splicing activity at the SD6140 site occurred or not in the presence of a functional SD6123 site, Southern blot analysis was performed on RT-PCR products produced from cells transfected with either pKRB1 or pKRmB1 plasmids containing native or mutated SD6123 site, respectively. Two radiolabeled probes were designed to specifically detect RNAs spliced at the SD6140 site (Fig. 2A, bottom). The probe MarN2 was targeted against the sequence located between the SD6123 and SD6140 sites, while the probe MarS overlapped the splice junction between the SD6140 and SA8514 sites. As shown in Fig. 2C, the SD6140 site promoted splicing of the SRLV env sequence even in the presence of the functional SD6123 site (lanes 2). As expected, the splicing activity at the SD6140 site greatly increased in the absence of the upstream competitive SD6123 site (lanes 1). These results demonstrated the functionality of the SD6140 site in the context of a wild-type viral sequence, and reinforced the potential complexity of the CAEV mRNA pool.
Characterization of the rtmORF
The specificities of these antibodies were as follows: i) anti-NH2 Env antibodies recognizing the 38 N-terminal amino acids of the Env precursor; ii) anti-CD™ antibodies recognizing the cytoplasmic domain of TM; iii) monospecific anti-Rev antibodies recognizing the 98 C-terminal amino acids of Rev. As shown in Fig. 3C, two major protein species of apparent molecular weights of 18- and 17-kDa expressed from cells transfected with the Rtm expression vector (lane 3) were immunoprecipitated with either anti-NH2 Env or anti-CD™ antibodies. A minor protein species with a size slightly smaller than 18-kDa was also immunoprecipitated with the anti-NH2 Env antibodies. None of these proteins were immunoprecipitated with monospecific anti-Rev antibodies. Two proteins exhibiting slightly different mobilities were immunoprecipitated from cells transfected with the Rev expression vector (lane 2) by using either anti-NH2 Env or anti-Rev antibodies, but not with anti-CD™ antibodies. No corresponding protein was immunoprecipitated from cells transfected with the empty parental plasmid pKCR3 (lane 1). These results demonstrated that the rtm ORF encoded two major protein isoforms carrying antigenic determinants derived from both the N- and C-termini of the Env precursor. As expected, these proteins did not share any antigenicity with the C-terminus of Rev. These two major protein isoforms of apparent molecular weights of 18- and 17-kDa corresponded likely to the expected proteins of 17.8- and 15.5-kDa, the minor band corresponding to the expected protein of 17-kDa. The fact that Rtm proteins were recognized by antibodies directed against both NH2 and COOH termini of the Env precursor indicated that they were not degradation products of the Env precursor.
Expression of two isoforms from cells transfected with the CAEV rev cDNA has been previously reported . It has been suggested that they resulted from initiation at the first methionine codon (position 6012) and from leaky scanning and initiation at one of the two downstream in frame initiation codons (positions 6033 and 6072) within the env gene (Fig. 3A), leading to a protein of 15.3-kDa and to an isoform of either 14.5- or 13-kDa, respectively. Since rev and rtm ORFs shared the same 5' coding region, it was likely that the Rtm-related isoforms resulted from a similar leaky translational mechanism. Alternatively, they could originate from an alternative splicing removing part of the rtm ORF. To discriminate between these two hypotheses, immunoprecipitations were performed from cells transfected with the plasmid pKRtm carrying the fully spliced rtm cDNA (Fig. 3B), which was obtained by RT-PCR from cells transfected with plasmid pKcRtm. Two major proteins with similar mobilities and antigenic properties were produced from cells transfected with pKcRtm and pKRtm plasmids (Fig. 3C, compare lanes 3 and 4), indicating that these protein isoforms did not result from alternative splicing of the rtm transcript. To rule out any post-translational modifications or protein degradations, the rtm cDNA was used as a template in an in vitro transcription-translation reaction. As shown in Fig. 3D, analysis of the cell-free radiolabeled translated proteins also revealed the two Rtm proteins (lane 3), which were specifically immunoprecipitated by anti-CD™ antibodies (lane 4), whereas no product was detected in mock experiments (lanes 1 and 2). Interestingly, the fact that the in vitro 18-kDa:17-kDa ratio was inversely related to that observed in vivo was in favor of a leaky scanning origin of the 17-kDa protein. Altogether, these results strongly suggested that the two isoforms of 18- and 17-kDa encoded by the rtm ORF resulted from translational initiation at different in frame start codons, as previously reported for Rev protein synthesis.
Splicing activity at the SD6140 site occurs in CAEV-infected cells, leading to the production of the rtmORF
Rtm is expressed in CAEV-infected cells
Next, we determined whether Rtm protein was expressed in CAEV-infected cells. A lysate from GSM cells infected by the CAEV-Cork strain was immunoprecipitated with either anti-Rtm or anti-CD™ antibodies. The two proteins of 18- and 17-kDa were clearly detected by both types of antibodies in infected cells whereas no product was detected in uninfected cells (Fig. 6C, compare lanes 2 and 4 with lanes 1 and 3). The signal using the anti-Rtm antibodies was faint compared with that obtained with the anti-CD™ antibodies, indicating probably a low peptide-antibody affinity. We concluded that the Rtm protein was expressed in CAEV-infected GSM cells.
To know whether the Rtm protein was expressed in infected animals we looked for humoral immune response against it. Considering that most antibodies that would recognize the Rtm protein might in fact result from an immune response against the Rev and/or Env proteins, we tested for the presence of antibodies recognizing the KYQPQIYRT Rtm-specific epitope. For this purpose, fifty milliliters of pooled sera from three seropositive goats experimentally infected with the CAEV-Cork strain were loaded onto a resin matrix covalently bound with the Rtm peptide. After extensive washing, bound antibodies were eluted and tested by ELISA using either the Rtm peptide or the GST-CD™ protein as antigens and by Western blot using the GST-CD™ protein. None of these assays provided positive results. We concluded that if the Rtm was expressed in infected animals the KYQPQIYRT epitope was not enough immunogenic to give rise to the production of antibodies or that these antibodies did not recognize the synthetic peptide.
Rtm protein interacts with the cytoplasmic domain of TM
These results clearly indicated that Rtm protein strongly and specifically interacts with the cytoplasmic domain of TM in vitro.
The SD6140site is strictly conserved throughout the SRLV phylum
Rtm protein affects the fusion activity of Env protein
Effects of Rtm on the fusion activity of Env protein.
No. of syncytia/well (293T/GSM cocultivation)b
% of syncytiac
954 ± 105
pKEnv + pKRtm
200 ± 46
A novel CAEV protein, designated Rtm, was characterized on the basis of its immunological cross-reactivity with antibodies directed against either the N-terminus of the Env precursor or the C-terminus of TM, and by cDNA sequence analysis which established that rtm ORF results from a novel splicing junction linking the 5' and 3' part ends of the env gene. Immunoprecipitation experiments using monospecific antibodies raised against the peptide encoded by the sequence straddling this splice junction confirmed the existence of the rtm ORF. Like Rev, the Rtm expression was initiated at the env ORF start codons and led to the production of two major protein isoforms of 18- and 17-kDa. Previous studies together with this work indicated that both Rev and Rtm protein doublets may be attributed to a leaky scanning at the first AUG initiation codon and initiation at one of the two downstream in frame env initiation codons [13, 23, 24]. The ratio between the 18- and 17-kDa isoforms depends on the context and/or the level of the Rtm expression, the 18-kDa being the major product in transfected 293T cells whereas the 17-kDa is the major product in infected GSM cells and in the in vitro transcription/translation reaction.
The rtm ORF was generated by splicing between the SD6140 site identified in this study and the well described SA8514 site. Since the rev ORF is produced by splicing between the SD6123 and SA8514 sites, the Rev and Rtm proteins are expressed from distinct but structurally closely related multiply-spliced mRNAs. The SD6140 site matched perfectly the canonical SD sequence and was highly conserved among all SRLV genomes. Moreover, the distance between the SD6123 and SD6140 sites is also strictly conserved among SRLV sequences, despite the variability of the surrounding region. Altogether, these results strongly suggested that the Rtm protein is an additional auxiliary factor required for successful SRLV propagation in vivo. The Rtm protein is a chimeric protein in which the N-terminal part of the envelope precursor is joined to the complete cytoplasmic domain of TM. An expression of this domain in a viral envelope-free context has been also reported for MVV in a previous study showing that a 16.5-kDa protein corresponding to the C-terminal domain of TM is produced in an in vitro transcription/translation reaction from the rev transcript by leaky scanning and initiation at a downstream initiation codon . For SRLVs, equine infectious anemia virus (EIAV), bovine and simian (SIV) immunodeficiency viruses, the 5' terminal part of the env gene also constitutes the first coding exon of Rev. Thus, Rtm could exhibit some functions of its related proteins, Rev and/or TM. Several studies demonstrated that motifs involved in CAEV Rev function are exclusively localized in the C-terminal domain of the protein [13, 27]. Moreover, a truncated Rev protein devoid of its N-terminal domain is still functional , although this domain has been shown to be responsible for optimal binding to the Rev responsive element . Our attempts to identify a Rev activity in Rtm were unsuccessful (data not shown). Altogether, these results strongly indicate that Rtm does not harbor any Rev activity. More likely, the biological functions of Rtm would be harbored by its C-terminus which corresponds precisely to the entire cytoplasmic domain of TM.
The cytoplasmic domain of the TM protein is considerably longer for lentiviruses than for other retroviruses , and has been reported to be involved in multiple crucial steps of virus infection, such as particle assembly, infectivity, replication, and pathogenesis. For HIV and SIV, the cytoplasmic domain of TM modulates Env fusogenicity, expression on the cell surface, and incorporation into viral particles as well as the biochemical and immunologic properties of the Env ectodomain [30–39]. The underlying mechanisms responsible for the regulation of Env protein function involve association of the cytoplasmic domain of TM with cellular and viral components [40–50]. These interactions require canonical tyrosine-based and di-leucine motifs as well as small domains called lentivirus lytic peptide. Since most of these signals were found in the cytoplasmic domain of CAEV TM (Fig. 5), it was likely that similar mechanisms have been developed by SRLVs to regulate the Env protein function. Consequently, expression of the cytoplasmic domain of TM in a viral glycoprotein-free context like Rtm could potentially interfere with Env protein function. We showed here that the Env-mediated syncytium induction is dramatically reduced in the presence of Rtm protein. Using a GST pull-down assay, we also found that Rtm protein interacts specifically with the cytoplasmic domain of TM. Altogether, these findings suggest that the Rtm protein acts in the infectious cycle of SRLV by modulating the Env protein function through direct interaction with the cytoplasmic domain of TM and/or through competitive interaction with cellular factors.
Assuming that Rtm acts as a down regulator of Env protein function, it is likely that Rtm is not expressed during the late phase of the viral cycle when Env proteins must be highly expressed, correctly sorted and incorporated in the virions. This is sustained by the fact that despite Rtm interacts strongly with the cytoplasmic domain of the TM, all our attempts to detect Rtm in virions failed (data not shown). Moreover, Rtm is translated from a multiply-spliced transcript, arguing in favor of its expression early during the viral replication cycle since previous studies have revealed a temporal shift from multiply-spliced to mono- and unspliced SRLV transcripts [20, 22]. Since the Rev protein is absolutely required for the expression of the viral structural proteins, we can hypothesize that expressions of Rev and Rtm proteins are temporally dissociated from each other. This assumption can accommodate with the fact that SRLV expression is restricted in monocytes, and upregulated during maturation of monocytes into macrophages [4, 5]. In latently infected monocytes, virus replication is blocked at a post-transcriptional stage [2, 4], which could result from the downregulation effects of Rtm. Differentiation of monocytes into macrophages is also required for EIAV expression . Interestingly, a very similar mRNA encoding a Rtm-like protein has been described in an acutely infected horse . This hybrid protein, designated Ttm, contains the domain encoded by the first coding exon of Tat fused to the complete cytoplasmic tail of TM. Similarly to the Rev-derived sequence in the Rtm protein, the Tat-derived sequence in the Ttm protein does not contain functional domains of the native protein. Thus, the role of the cytoplasmic domain of TM expressed in these two similar hybrid proteins would be interesting to examine in the context of the high variation of viral expression of these two macrophage-tropic lentiviruses in their hosts.
In the present study we have identified a new competent SD site at position 6140 in the CAEV genome that presents two remarkable features. First, despite its location within a highly variable region, the sequence of this SD site is perfectly conserved among CAEV and MVV strains, the only other conserved stretch of nucleotides in this region corresponding to the SD site used for the rev mRNA synthesis. Second, the 17 nt distance between the two SD sites is also strictly conserved in the genome of all SRLV isolates. Splicing at the SD6140 site was demonstrated in both transfected and CAEV-infected cells, leading to the production of an ORF encoding two major protein isoforms of 18- and 17-kDa, named Rtm. These proteins are generated by differential translation initiation, contain the N-terminal part of the Env precursor fused to the complete 110-amino acid cytoplasmic domain of TM, and are expressed in CAEV-infected cells. The exceptional degree of conservation of the SD6140 site sequence among CAEV and MVV isolates and the fact that rtm and rev transcripts were structurally closely related strongly suggest that the Rtm protein is a fourth important auxiliary factor of SRLVs. We showed that this protein interacts specifically with the cytoplasmic domain of TM and dramatically affects the fusion activity of Env protein. Altogether, these findings support a model of regulation of SRLV expression by a new viral factor, which can accommodate confirmed observations regarding SRLV infection in vivo. In this aspect, the functional activity of the cytoplasmic domain of the TM expressed in a viral glycoprotein-free context should be considered to better understand the parameters of SRLV propagation in vivo.
Cells and sera
Primary foetal goat synovial membrane (GSM) cells infected with CAEV-Cork strain were maintained in culture in Eagle's minimal essential medium supplemented with 1% glutamine, 200 U/ml penicillin, 200 μg/ml streptomycin, 5 μg/ml fungizone, and 10% foetal bovine serum (FBS). The human 293T cell line was propagated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% glutamine, 25 μg/ml gentamycin, and 5% FBS. CAEV-specific sera were collected from goats experimentally infected with CAEV-Cork strain. Rabbit polyclonal antisera against the cytoplasmic domain of TM (anti-CD™), the N-terminus of Env precursor (anti-NH2 Env), and the C-terminus of Rev (anti-Rev) were generated by using GST fusion proteins as immunogens. Purified fusion proteins were used in association with Freund adjuvant to immunize New Zealand White rabbits. Rabbit antisera were affinity purified on GST fusion protein/affi-gel 10 columns according to the manufacturer's instructions (BIO-RAD).
A synthetic peptide derived from the predicted Rtm open reading frame (ORF) product (amino acids 39 to 47) was designed for the production of monospecific anti-Rtm antibodies. This Rtm-specific peptide (KYQPQIYRT) was synthesized using a 9-fluorenylmethyloxycarbonyl chemical strategy (Sigma-Genosys) and rabbit peptide-specific antiserum was generated by immunization with the peptide cross-linked to the keyhole limpet hemocyanin carrier.
All eukaryotic expression plasmids were derived from the pKCR3 vector  in which the rabbit β-globin intron 2 flanked by its splice sites was inserted between the early promoter and polyA signal site of the simian virus 40 (SV40). The viral sequences were derived from both the 9-kbp and 0.5-kbp HindIII clones of CAEV-Cork strain [22, 54]. The nucleotides (nt) are numbered according to the Cork sequence . To generate constructs used for splicing activity assays, a fragment (nt 6117 to 6674) spanning the well-described SD6123 site and the putative SD6140 site was PCR-amplified from the 9-kbp HindIII clone, and subcloned into the SmaI site of pGEM-1 plasmid. Disruption of the SD6123 site (G to C substitution at nt 6124) was achieved with primer 5'-TCTAAAGGATCCCCCAGCAAGCTAAGTATCAACCCCAG-3' (non CAEV sequences are shown in italic) by using the CLONTECH Transformer site-directed mutagenesis kit (mutated nt are underlined in the nucleotide sequences). A 261-bp fragment containing either the wild-type or mutated viral sequence was double digested with BamHI (in the multiple cloning site [MCS] of pGEM-1) and HincII (position 6369 in Cork sequence), and cloned in place of the original β-globin SD site in the pKCR3 plasmid, to generate pKR12 and pKRm plasmids, respectively. The plasmids pKRB1 and pKRmB1 were generated by inserting the ApaI-BamHI fragment of the 0.5-kbp HindIII clone (nt 8113 to 9251) into the ApaI-BglII-digested pKR12 and pKRm plasmids, respectively.
To generate eukaryotic expression plasmids coding for Env, Rev and Rtm proteins, the SpeI-BamHI fragment of the 9-kbp HindIII clone, containing the env initiation codon (nt 6012) and both the SD6123 and SD6140 sites, was cloned into the XbaI/BamHI-digested pGEM-1 plasmid. To facilitate cloning, a BamHI site was introduced by site-directed mutagenesis at position 5979, upstream the env initiation codon, using the primer 5'-TGCAAATAAATGGATCCAACAAGTAGCAAAAGT-3' (nt 5968 to 6000). Mutagenic primers 5'-GGGACAGCAAGCTAAGTATCAA-3' (nt 6113 to 6134) and 5'-TATCAACCCCAGCTAAGTAAGCAA-3' (nt 6129 to 6152) were used to disrupt the SD6123 and SD6140 sites, respectively. The resulting 231-bp BamHI-EcoRV fragments (nt 5980 to 6211) containing either the mutated SD6123 site or the mutated SD6140 site were cloned into the similarly-digested pKRmB1 to produce pKcRtm and pKcRev plasmids, respectively. The pKEnv plasmid was generated by cloning the EcoRI-BstXI fragment (nt 6348 to 8368) of the 9-kbp HindIII clone into the similarly-digested pKcRev plasmid. The Plasmids encoding the Rtm protein from the cDNA were generated as follows. Two PCR primers were used to amplify cDNA from 293T cells transfected with pKcRtm. Forward primer M5e (5'-GGAATTCATGGATGCTGGGGCCAGATAC-3'; nt 6012 to 6032) and reverse primer M3b (5'-CGGGATCCGCAAGCAGCAAGCTTCTCCTTATATA-3'; nt 9098 to 9073) contained EcoRI and BamHI sites at their 5' end, respectively. The EcoRI-BamHI digested PCR product was cloned into pKCR3 digested with EcoRI and BglII to produce plasmid pKRtm. The same digested PCR product was cloned under the T7 promoter control between the EcoRI/BamHI sites of pGEM-1, generating the pGRtm plasmid used as template in cell-free transcription/translation reaction. All clones were verified by sequencing.
RNA isolation and RT-PCR
RNAs were extracted from either transfected 293T cells or infected GSM cells with the RNA Now extraction kit (Biogentex) according to the manufacturer's protocol. Five micrograms of Dnase-treated RNAs were used for reverse transcription in a final volume of 20 μl containing 200 U of Moloney murine leukemia virus reverse transcriptase (Promega), 1 mM of each deoxynucleoside triphosphate (dNTPs), 1 mM DTT, 500 ng of oligo(dT)12–18 and 26 U of RNase inhibitor (Amersham). Reverse transcription (RT) was carried out for 15 min at 37°C and then for 45 min at 42°C. PCR amplifications were carried out in a final volume of 50 μl of 1× PCR buffer (Perkin-Elmer), with 200 μM (each) dNTPs, 2 mM MgCl2, 100 ng of each primer, 0.5 U AmpliTaq DNA polymerase (Perkin-Elmer), and 10 μl of cDNA, using the following conditions: 3 min denaturation at 94°C, followed by 35 amplification cycles of 40 sec at 94°C, 50 sec at 53°C, 50 sec at 72°C, followed by a final 4 min extension step at 72°C. Nested-PCR reactions were performed under similar conditions using one-tenth of the RT-PCR products as templates. PCR products were separated by 2.5% agarose electrophoresis and visualized by ethidium bromide staining. After blotting onto a nylon membrane (Hybond-N+, Amersham), the membrane was prehybridized for 3 h at 46°C in 5× SSC (1× SSC is 0.15 M NaCl plus 0.15 M sodium citrate), 0.5% sodium dodecyl sulfate (SDS), 100 μg/ml salmon sperm DNA. The prehybridization solution was then replaced by the hybridization solution containing the 32P-labeled oligonucleotide probe. After overnight incubation at 46°C, the membrane was washed four times with 2× SSC – 0.1% SDS at room temperature for 15 min and then once with 1× SSC – 0.1% SDS at 46°C for 15 min before being exposed to X-ray film (Kodak) at -70°C. The oligonucleotide used to detect messages spliced at the SD6140 site was MarN2 (5'-AGGTAAGTATCAACCCCAG-3'; nt 6122 to 6140). The oligonucleotide used to detect Rtm-specific spliced message was MarS (5'-AGTATCAACCCCAGATATACAGAAC-3'; nt 6127 to 6140 and nt 8514 to 8524), which overlapped the splice junction between the SD6123 and SA8514 sites.
Two primer pairs were alternatively used in a first round PCR reaction to amplify cDNAs from transfected cells: PK5 (5'-TAGTGAGGAGGCTTTTTTGGAG-3'; forward primer) and PK3 (5'-GAAGATCTCAGTGGTATTTGTGAGCCA-3'; reverse primer), both located in pKCR3 sequence, or PK5 and M3b. The primer pair used in a first round PCR reaction to amplify cDNAs from infected GSM cells were Mar52 (5'-TAATCTGTGCAATACCAGAGCGGCT-3'; nt 131 to 155; forward primer) and M3b. Primer pair MarN (5'-CAGCAAGGTAAGTATCAACCCCAG-3'; nt 6117 to 6140; forward primer) and M3b was used in a second round PCR reaction.
Construction of GST fusion proteins
Plasmids pGST-NH2 Env, pGST-Rev, and pGST-CD™ encode the gluthatione S-transferase (GST) fused C-terminally to the N-terminus of Env precursor (amino acids 1 to 38), the C-terminus of Rev (amino acids 36 to 133), and the cytoplasmic domain of TM (amino acids 203 to 312), respectively. To generate pGST-NH2 Env, a PCR product was amplified from pGRtm by using primers M5e and 5'-CGCGGATCCTTGCTGTCCCGCAGTGAAACCT-3', digested with EcoRI-BamHI, and then cloned into the EcoRI/BglII sites of pGEX-A (Pharmacia). To generate the GST-Rev fusion protein, cDNA from 293T cells transfected with pKRB1 was used as template to amplify by PCR the Rev C-terminus coding region by using primers PK5 and M3x (5'-TGTCTAGAGCAAGCAGCAAGCTTCTCCTTATATA-3'; nt 9098 to 9073). The PCR product was digested with EcoRI-XbaI and then cloned into the corresponding sites of pGEM-1. Then, a BamHI/HincII fragment encoding the C-terminal domain of Rev was excised and subcloned into the BamHI/SmaI sites of pGEX-3X (Pharmacia). Similar cloning strategy was applied to cDNA from 293T cells transfected with pKRmB1 to generate pGST-CD™. GST fusion proteins were produced in Escherichia coli strain DH5α and purified by using Glutathione-Sepharose 4B beads (Pharmacia Biotech) by standard procedures .
Metabolic labeling and immunoprecipitation
The 293T cells were transfected by the calcium phosphate coprecipitation technique . At 48 h post-transfection, 293T cells were incubated for 30 min in methionine/cysteine-free DMEM supplemented with 5% dialyzed FBS and then metabolically labeled for 5 h with 100 μCi of [35S] methionine/cysteine mixture (Promix; Amersham) per ml. Cells were then lysed in 1× RIPA buffer (10 mM Tris-HCl [pH 7.8], 1 mM Na2HPO4, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate, 0.2 mM PMSF), and cell lysates were cleared by centrifugation at 15,000 × g for 15 min at 4°C. Immunoprecipitation reactions were performed by incubating cell lysates with protein A-Sepharose beads and either 300 μl of affinity-purified rabbit antibodies or 5 μl of serum from CAEV-Cork infected goat preadsorbed on normal 293T cell lysate, overnight at 4°C with rocking. The bead-antibody-protein complexes were washed five times with RIPA buffer, boiled in sample loading buffer (60 mM Tris-HCl [pH 6.8], 1% SDS, 1% β-mercaptoethanol, 10% glycerol, 0.01% bromophenol blue), and recovered proteins were subjected to SDS-15% polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The gel was fixed, soaked in Amplify (Amersham) for 30 min, dried and autoradiographied.
Cell fusion activity
The 293T cells were plated (2 × 105 cells per well) in triplicate in six-well plates in complete DMEM the day prior transfection. The cells were transfected with 1.5 μg of pKEnv plasmid or cotransfected with 1.5 μg of pKEnv plasmid and 1.5 μg of pKRtm plasmid. The copy number of the SV40 promotor was normalized in each transfection by adding appropriate amounts of empty plasmid (pKCR3). On the next day, primary GSM cells (2.5 × 105 cells per well) were added to transfected cells. One day post-coculture, cells were fixed and stained to visualize nuclei. Fusion activity was assessed by counting syncytia in 30 randomly selected fields at 100× magnification of each well.
In vitrotranscription and translation
One microgram of linearized plasmids pGRtm or pGEM-1 were transcribed and translated in a coupled rabbit reticulocyte lysate system (Promega) according to the manufacturer's instructions with T7 RNA polymerase and 0.8 μCi/μl of [35S] methionine/cysteine mixture (Amersham) in a final volume of 50 μl. The translated products were analyzed on SDS-PAGE and detected by autoradiography. Immunoprecipitations of translation products with affinity purified anti-CD™ antibodies were carried out as described above.
GST pull-down assays
Equal amounts, as judged by Coomassie blue staining, of the different GST fusion proteins complexed to glutathione-Sepharose beads were incubated with 10 μl of [35S]-labeled Rtm protein produced from in vitro transcription/translation reaction, in binding buffer (10 mM Tris [pH 7.4], 10% glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.25% Triton X-100) supplemented with 80 mM KCl and 100 μg/ml of bovine serum albumin in a final volume of 300 μl overnight at 4°C with constant agitation. The beads were washed six times in binding buffer containing different concentrations of KCl (150 mM, 300 mM, or 500 mM), boiled in sample loading buffer, and the proteins were subjected to 15% SDS-PAGE analysis and autoradiography as described above.
This work was supported by grants from AFSSA and from the Etablissements Publics Régionaux de Poitou-Charentes et d'Aquitaine.
- Narayan O, Clements JE: Biology and pathogenesis of lentiviruses. J Gen Virol. 1989, 70: 1617-1639.View ArticlePubMedGoogle Scholar
- Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z: Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA. 1985, 82: 7086-7090. 10.1073/pnas.82.20.7086.PubMed CentralView ArticlePubMedGoogle Scholar
- Narayan O, Wolinsky JS, Clements JE, Strandberg JD, Griffin DE, Cork LC: Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol. 1982, 59: 345-356.View ArticlePubMedGoogle Scholar
- Gendelman HE, Narayan O, Kennedy-Stoskopf S, Kennedy PG, Ghotbi Z, Clements JE, Stanley J, Pezeshkpour G: Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol. 1986, 58: 67-74.PubMed CentralPubMedGoogle Scholar
- Narayan O, Kennedy-Stoskopf S, Sheffer D, Griffin DE, Clements JE: Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun. 1983, 41: 67-73.PubMed CentralPubMedGoogle Scholar
- Filippi P, Vigne R, Quérat G, Jouanny C, Sauze N: Intracellular ribonucleoprotein complexes of visna virus are infectious. J Virol. 1982, 42: 1057-1066.PubMed CentralPubMedGoogle Scholar
- Haziza B, Chauvin JP, Gluschankof P, Suzan M: Caprine arthritis encephalitis virus: evidence for a B/D-type assembly pathway in a C-type lentivirus replication. Virology. 2001, 286: 434-445. 10.1006/viro.2001.1000.View ArticlePubMedGoogle Scholar
- Lairmore MD, Akita GY, Russell HI, DeMartini JC: Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol. 1987, 61: 4038-4042.PubMed CentralPubMedGoogle Scholar
- Lee WC, McConnell I, Blacklaws BA: Electron microscope studies of the replication of a British isolate of maedi visna virus in macrophages and skin cell lines. Vet Microbiol. 1996, 49: 93-104. 10.1016/0378-1135(95)00170-0.View ArticlePubMedGoogle Scholar
- Davis JL, Clements JE: Characterization of a cDNA clone encoding the visna virus trans-acting protein. Proc Natl Acad Sci USA. 1989, 86: 414-418. 10.1073/pnas.86.2.414.PubMed CentralView ArticlePubMedGoogle Scholar
- Hess JL, Pyper JM, Clements JE: Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat. J Virol. 1986, 60: 385-393.PubMed CentralPubMedGoogle Scholar
- Villet S, Bouzar BA, Morin T, Verdier G, Legras C, Chebloune Y: Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein. J Virol. 2003, 77: 9632-9638. 10.1128/JVI.77.17.9632-9638.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Schoborg RV, Saltarelli MJ, Clements JE: A rev protein is expressed in caprine arthritis encephalitis virus (CAEV)-infected cells and is required for efficient viral replication. Virology. 1994, 202: 1-15. 10.1006/viro.1994.1316.View ArticlePubMedGoogle Scholar
- Tiley LS, Brown PH, Le SY, Maizel JV, Clements JE, Cullen BR: Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci USA. 1990, 87: 7497-7501. 10.1073/pnas.87.19.7497.PubMed CentralView ArticlePubMedGoogle Scholar
- Harmache A, Bouyac M, Audoly G, Hieblot C, Peveri P, Vigne R, Suzan M: The vif gene is essential for efficient replication of caprine arthritis encephalitis virus in goat synovial membrane cells and affects the late steps of the virus replication cycle. J Virol. 1995, 69: 3247-3257.PubMed CentralPubMedGoogle Scholar
- Harmache A, Russo P, Guiguen F, Vitu C, Vignoni M, Bouyac M, Hieblot C, Pepin M, Vigne R, Suzan M: Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology. 1996, 224: 246-255. 10.1006/viro.1996.0526.View ArticlePubMedGoogle Scholar
- Kristbjornsdottir HB, Andresdottir V, Svansson V, Torsteinsdottir S, Matthiasdottir S, Andresson OS: The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro. Virology. 2004, 318: 350-359. 10.1016/j.virol.2003.09.044.View ArticlePubMedGoogle Scholar
- Kalinski H, Yaniv A, Mashiah P, Miki Y, Tronick SR, Gazit A: Rev-like transcripts of caprine arthritis encephalitis virus. Virology. 1991, 183: 786-792. 10.1016/0042-6822(91)91012-6.View ArticlePubMedGoogle Scholar
- Schoborg RV: Analysis of caprine arthritis encephalitis virus (CAEV) temporal gene expression in infected cells. Virus Res. 2002, 90: 37-46. 10.1016/S0168-1702(02)00143-0.View ArticlePubMedGoogle Scholar
- Vigne R, Barban V, Querat G, Mazarin V, Gourdou I, Sauze N: Transcription of visna virus during its lytic cycle: evidence for a sequential early and late gene expression. Virology. 1987, 161: 218-227. 10.1016/0042-6822(87)90188-7.View ArticlePubMedGoogle Scholar
- Gazit A, Mashiah P, Kalinski H, Gast A, Rosin-Abersfeld R, Tronick SR, Yaniv A: Two species of rev proteins, with distinct N termini, are expressed by caprine arthritis encephalitis virus. J Virol. 1996, 70: 2674-2677.PubMed CentralPubMedGoogle Scholar
- Saltarelli M, Querat G, Konings DA, Vigne R, Clements JE: Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology. 1990, 179: 347-364. 10.1016/0042-6822(90)90303-9.View ArticlePubMedGoogle Scholar
- Mazarin V, Gourdou I, Querat G, Sauze N, Vigne R: Genetic structure and function of an early transcript of visna virus. J Virol. 1988, 62: 4813-4818.PubMed CentralPubMedGoogle Scholar
- Saltarelli MJ, Schoborg R, Pavlakis GN, Clements JE: Identification of the caprine arthritis encephalitis virus rev protein and its cis-acting rev-response element. Virology. 1994, 199: 47-55. 10.1006/viro.1994.1096.View ArticlePubMedGoogle Scholar
- Sherman L, Gazit A, Yaniv A, Dahlberg JE: Nucleotide sequence analysis of the long terminal repeat of integrated caprine arthritis encephalitis virus. Virus Res. 1986, 5: 145-155. 10.1016/0168-1702(86)90014-6.View ArticlePubMedGoogle Scholar
- Lee SF, Wang CT, Liang JY-P, Hong SL, Huang CC, Chen SS-L: Multimerization potential of the cytoplasmic domain of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J Biol Chem. 2000, 275: 15809-15819. 10.1074/jbc.M000601200.View ArticlePubMedGoogle Scholar
- Schoborg RV, Clements JE: Definition of the RRE binding and activation domains of the caprine arthritis-encephalitis virus rev protein. Virology. 1996, 226: 113-121. 10.1006/viro.1996.0633.View ArticlePubMedGoogle Scholar
- Abelson ML, Schoborg RV: Characterization of the caprine arthritis encephalitis virus (CAEV) rev N-terminal elements required for efficient interaction with the RRE. Virus Res. 2003, 92: 23-35. 10.1016/S0168-1702(02)00311-8.View ArticlePubMedGoogle Scholar
- Hunter E, Swanstrom R: Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol. 1990, 157: 187-253.PubMedGoogle Scholar
- Day JR, Munk C, Guatelli JC: The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity. J Virol. 2004, 78: 1069-1079. 10.1128/JVI.78.3.1069-1079.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Dubay JW, Roberts SJ, Hahn BH, Hunter E: Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol. 1992, 66: 6616-6625.PubMed CentralPubMedGoogle Scholar
- Edwards TG, Wyss S, Reeves JD, Zolla-Pazner S, Hoxie JA, Doms RW, Baribaud F: Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J Virol. 2002, 76: 2683-2691. 10.1128/JVI.76.6.2683-2691.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Kalia V, Sarkar S, Gupta P, Montelaro RC: Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41. J Virol. 2005, 79: 2097-2107. 10.1128/JVI.79.4.2097-2107.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Piller SC, Dubay JW, Derdeyn CA, Hunter E: Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity. J Virol. 2000, 74: 11717-11723. 10.1128/JVI.74.24.11717-11723.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Sauter MM, Pelchen-Matthews A, Bron R, Marsh M, LaBranche CC, Vance PJ, Romano J, Haggarty BS, Hart TK, Lee WMF, Hoxie JA: An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. Journal of Cell Biology. 1996, 132: 795-811. 10.1083/jcb.132.5.795.View ArticlePubMedGoogle Scholar
- Spies CP, Ritter GD, Mulligan MJ, Compans RW: Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol. 1994, 68: 585-591.PubMed CentralPubMedGoogle Scholar
- Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA: Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol. 2005, 79: 12231-12241. 10.1128/JVI.79.19.12231-12241.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Ye L, Bu Z, Vzorov A, Taylor D, Compans RW, Yang C: Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain. J Virol. 2004, 78: 13409-13419. 10.1128/JVI.78.24.13409-13419.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Yu X, Yuan X, McLane MF, Lee T-H, Essex M: Mutations in the domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of env proteins into mature virions. J Virol. 1993, 67: 213-221.PubMed CentralPubMedGoogle Scholar
- Berlioz-Torrent C, Shacklett BL, Erdtmann L, Delamarre L, Bouchaert I, Sonigo P, Dokhelar MC, Benarous R: Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adapter complexes modulate intracellular and cell surface expression of envelope glycoproteins. J Virol. 1999, 73: 1350-1361.PubMed CentralPubMedGoogle Scholar
- Blot G, Janvier K, Le Panse S, Benarous R, Berlioz-torrent C: Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for env incorporation into virions and infectivity. J Virol. 2003, 77: 6931-6945. 10.1128/JVI.77.12.6931-6945.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Boge M, Wyss S, Bonifacino JS, Thali M: A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J Biol Chem. 1998, 273: 15773-15778. 10.1074/jbc.273.25.15773.View ArticlePubMedGoogle Scholar
- Bowers K, Matthews A, Honing S, Vance PJ, Creary L, Haggarty BS, Romano J, Ballensiefen W, Hoxie JA, Marsh M: The simian immunodeficiency virus envelope glycoprotein contains multiple signals that regulate its cell surface expression and endocytosis. Traffic. 2000, 1: 661-674. 10.1034/j.1600-0854.2000.010810.x.View ArticlePubMedGoogle Scholar
- Bultmann A, Muranyi W, Seed B, Haas J: Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression. J Virol. 2001, 75: 5263-5276. 10.1128/JVI.75.11.5263-5276.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Chan WE, Chen SS-L: Downregulation of human immunodeficiency virus type 1 gag expression by a gp41 cytoplasmic domain fusion protein. Virology. 2006, 348: 418-429. 10.1016/j.virol.2006.01.010.View ArticlePubMedGoogle Scholar
- Cosson P: Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 1996, 15: 5783-5788.PubMed CentralPubMedGoogle Scholar
- Kalia V, Sarkar S, Gupta P, Montelaro RC: Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation. J Virol. 2003, 7: 3634-3646. 10.1128/JVI.77.6.3634-3646.2003.View ArticleGoogle Scholar
- Ohno H, Aguilar RC, Fournier MC, Hennecke S, Cosson P, Bonifacino JS: Interaction of endocytosis signals from the HIV-1 envelope glycoprotein complex with members of the adapter medium chain family. Virology. 1997, 238: 305-315. 10.1006/viro.1997.8839.View ArticlePubMedGoogle Scholar
- Vincent MJ, Melsen LR, Martin AS, Compans RW: Intracellular interaction of simian immunodeficiency virus gag and env proteins. J Virol. 1999, 73: 8138-8144.PubMed CentralPubMedGoogle Scholar
- Wyss S, Berlioz-Torrent C, Boge M, Blot G, Honing S, Benarous R, Thali M: The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor. J Virol. 2001, 75: 2982-2992. 10.1128/JVI.75.6.2982-2992.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Sellon DC, Walker KM, Russell KE, Perry ST, Covington P, Fuller FJ: Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses. J Virol. 1996, 70: 590-594.PubMed CentralPubMedGoogle Scholar
- Beisel CE, Edwards JF, Dunn LL, Rice NR: Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein. J Virol. 1993, 67: 832-842.PubMed CentralPubMedGoogle Scholar
- Landais D, Waltzinger C, Beck BN, Staub A, McKean DJ, Benoist C, Mathis D: Functional sites on Ia molecules : a molecular dissection of A alpha immunogenicity. Cell. 1986, 47: 173-181. 10.1016/0092-8674(86)90440-X.View ArticlePubMedGoogle Scholar
- Pyper JM, Clements JE, Gonda MA, Narayan O: Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses. J Virol. 1986, 58: 665-670.PubMed CentralPubMedGoogle Scholar
- Smith DB, Corcoran LM: Current protocols in molecular biology. Edited by: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JD, Smith JA, Struhl K. 1994, New York: Wiley and Sons, 2:Google Scholar
- Graham FJ, van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973, 52: 456-460. 10.1016/0042-6822(73)90341-3.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.